OBJECTIVE: To study the effect of combined modality therapy on perennial allergic rhinitis (PAR). METHOD: Fifty-eight cases of PAR received a 4-weeks treatment with combined beclomethasone dipropionate nasal spray (BDP), cetirizine hydrochloride, ethmoidal nerve radiofrequency treatment, and half-dose combined BDP, cetirizine hydrochlonde was used for improving the recurrence symptoms in one year follow-up. RESULT: The overall effective (excellent/good) rate was 94.83% (excellent 72.41%, good 22.41%). The recurrence rate was 51.72%, but symptoms of 27 recurrence cases were lighter than pre-treatment. All treatments were well tolerated, and no serious adverse events occurred. CONCLUSION: The reasonable combined modality therapy is aimed at the complicated pathogenesis of PAR, and the curative effect is satisfactory, so it is a good way to treat PAR.
OBJECTIVE: To study the effect of combined modality therapy on perennial allergic rhinitis (PAR). METHOD: Fifty-eight cases of PAR received a 4-weeks treatment with combined beclomethasone dipropionate nasal spray (BDP), cetirizine hydrochloride, ethmoidal nerve radiofrequency treatment, and half-dose combined BDP, cetirizine hydrochlonde was used for improving the recurrence symptoms in one year follow-up. RESULT: The overall effective (excellent/good) rate was 94.83% (excellent 72.41%, good 22.41%). The recurrence rate was 51.72%, but symptoms of 27 recurrence cases were lighter than pre-treatment. All treatments were well tolerated, and no serious adverse events occurred. CONCLUSION: The reasonable combined modality therapy is aimed at the complicated pathogenesis of PAR, and the curative effect is satisfactory, so it is a good way to treat PAR.